Interference studies by siRNA evidenced that FKBP51 can prevent the proliferation of colorectal adenocarcinoma, whereas antagonists of the GR impair the effect of transfections of siRNA for FKBP51 on colorectal adenocarcinoma development. Here, FKBP4 is linked to colorectal adenocarcinoma.